480 related articles for article (PubMed ID: 25996427)
1. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.
Alagöz C; Alagöz N; Özkaya A; Çelik U; Turan MF; Yazici AT; Çekiç O; Demirok A
Retina; 2015 Oct; 35(10):2001-10. PubMed ID: 25996427
[TBL] [Abstract][Full Text] [Related]
2. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
Kim J; Dalziel D
Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Bhatnagar P; Freund KB; Spaide RF; Klancnik JM; Cooney MJ; Ho I; Fine HF; Yannuzzi LA
Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Bevacizumab for Choroidal Neovascularization Associated with Angioid Streaks: Long-term Results.
Lekha T; Prasad HN; Sarwate RN; Patel M; Karthikeyan S
Middle East Afr J Ophthalmol; 2017; 24(3):136-142. PubMed ID: 29279654
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
[TBL] [Abstract][Full Text] [Related]
7. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study.
Rosina C; Romano M; Cigada M; de Polo L; Staurenghi G; Bottoni F
Eur J Ophthalmol; 2015; 25(1):47-50. PubMed ID: 25044143
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study.
Iacono P; Battaglia Parodi M; La Spina C; Bandello F
Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066
[TBL] [Abstract][Full Text] [Related]
11. Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.
Schiano Lomoriello D; Parravano MC; Chiaravalloti A; Varano M
Eur J Ophthalmol; 2009; 19(1):151-3. PubMed ID: 19123166
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
[TBL] [Abstract][Full Text] [Related]
13. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
Derriman L; Marshall J; Moorman C; Downes SM
Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
[No Abstract] [Full Text] [Related]
14. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.
Battaglia Parodi M; Iacono P; La Spina C; Berchicci L; Scotti F; Leys A; Introini U; Bandello F
Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
Rinaldi M; Dell'Omo R; Romano MR; Chiosi F; Cipollone U; Costagliola C
Arch Ophthalmol; 2007 Oct; 125(10):1422-3. PubMed ID: 17923555
[No Abstract] [Full Text] [Related]
16. [Subretinal neovascular membrane in angioid streaks treated with intravitreal bevacizumab].
García-López A; González-Castaño C
Arch Soc Esp Oftalmol; 2014 May; 89(5):203-6. PubMed ID: 24269464
[TBL] [Abstract][Full Text] [Related]
17. [The results of intravitreal bevacizumab in subretinal neovascularisation in angioid streaks].
Brănişteanu D; Moraru A
Oftalmologia; 2014; 58(1):48-55. PubMed ID: 25147904
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.
Mimoun G; Tilleul J; Leys A; Coscas G; Soubrane G; Souied EH
Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
